Review
Copyright ©The Author(s) 2023.
World J Cardiol. Nov 26, 2023; 15(11): 553-570
Published online Nov 26, 2023. doi: 10.4330/wjc.v15.i11.553
Figure 1
Figure 1 Factors implicated in development of cardiovascular disease in patients with inflammatory bowel disease. JAK: Janus kinase; ASA: Amino salicylic acid; TNF: Tumor necrosis factor; CVD: Cardiovascular diseases; IBD: Inflammatory bowel disease; VEGF: Vascular endothelial growth factor; IFN-γ: Interferon-gamma; CRP: C-reactive protein; S1P: Sphingosine-1-phosphate; IL: Interleukin.
Figure 2
Figure 2 Duration of anticoagulation in inflammatory bowel disease patients with venous thromboembolism. IBD: Inflammatory bowel disease; VTE: Venous thromboembolism.
Figure 3
Figure 3 Prevalence of risk factors for atherosclerotic cardiovascular disease in patients with inflammatory bowel disease.